PHD EXPERIMENTAL AND SYSTEMS MEDICINE in Rome

PHD EXPERIMENTAL AND SYSTEMS MEDICINE in Rome

Rome Full-Time In sede
University of Rome Tor Vergata

First Stage Researcher (R1) (Up to the point of PhD) Not funded by a EU programme About

Outline The PhD program is focused into five research topics in the Internal Medicine area: (a) Metabolic disorders (Obesity, Diabetes, NAFLD, Atherosclerosis) (b) Cardiovascular disorders, (c) Mucosal Inflammation disorders (Inflammatory Bowel Disease), (d) Clinical Oncology, (s) Respiratory disorders. The course is organized in three years with compulsory laboratory attendance during the academic year. At the beginning of the first academic year, students will be assigned a research project and a laboratory supervisor in accordance with the purpose of the course. - STABLE-AMI study, to evaluate early therapies for the prevention of atherosclerosis Acute myocardial infarction (AMI) is a frequent cause of morbidity and mortality in diabetic patients, who present a very high cardiovascular risk. Despite advances in percutaneous revascularization, up to one-fifth of AMI patients undergoing primary percutaneous coronary intervention (PCI) require repeat revascularization within 3 years, driven equally by in-stent restenosis and coronary artery disease (CAD) progression in non-culprit sites. Diabetes mellitus promotes revascularization failure due to high atherosclerotic burden linked to dyslipidemia, endothelial dysfunction, and chronic inflammation. Targeted therapies are therefore needed to stabilize vulnerable plaques. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) improve cardiovascular prognosis and reduce ischemic events in ischemic heart disease, though underlying mechanisms remain unclear; retrospective studies suggest a potential plaque-stabilizing effect. Coronary computed tomography angiography (CCTA), thanks to its high spatial resolution, enables early non-invasive detection of CAD progression in native and stented vessels, quantifying plaque burden and analyzing its morphology. Objectives. To evaluate the effect of SGLT2i on coronary plaque stabilization in diabetic patients with AMI undergoing primary PCI. The responsibility for the funding offers published on this website, including the funding description, lies entirely with the publishing institutions. The application is handled uniquely by the employer, who is also fully responsible for the recruitment and selection processes.

PHD EXPERIMENTAL AND SYSTEMS MEDICINE in Rome datore di lavoro: University of Rome Tor Vergata

L'Università di Roma Tor Vergata è un datore di lavoro eccezionale, offrendo un ambiente di ricerca stimolante e opportunità di crescita professionale per neurologi clinici e ricercatori. I dipendenti possono beneficiare di un team multidisciplinare, accesso a risorse all'avanguardia e la possibilità di contribuire a progetti innovativi nel campo dell'epilettologia e dei disturbi del sonno, rendendo ogni giorno di lavoro significativo e gratificante.

University of Rome Tor Vergata

Dettagli di contatto:

Team di recruiting di University of Rome Tor Vergata